CARISOPRODOL

Product NDC: 55700-770
11-digit product format: 557000770
Labeler code: 55700
Product ID: 55700-770_c1ea1132-4ec4-4e09-a058-8fe2bac54780
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: CARISOPRODOL
Dosage form: TABLET
Route: ORAL
Labeler: Quality Care Products, LLC
Application: ANDA203374
Marketing category: ANDA
Marketing start: 2019-06-28
Marketing end: 0000-00-00
Substance: CARISOPRODOL
Active strength: 350 mg/1
Pharmacologic classes: Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
DEA schedule: CIV
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	55700-770		D	Discontinued by firm	2026-08-17
excluded package	package	55700-770	55700-770-01	D	Discontinued by firm	2026-08-17
excluded package	package	55700-770	55700-770-30	D	Discontinued by firm	2026-08-17
excluded package	package	55700-770	55700-770-60	D	Discontinued by firm	2026-08-17
excluded package	package	55700-770	55700-770-90	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 75 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55700-770-30	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55700-770-60	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55700-770-01	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55700-770-90	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	55700-770-30	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	55700-770-60	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	55700-770-01	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	55700-770-90	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55700-770-30	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55700-770-60	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55700-770-01	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55700-770-90	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55700-770-30	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55700-770-60	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55700-770-01	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55700-770-90	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55700-770-30	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55700-770-60	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55700-770-01	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55700-770-90	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55700-770-30	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55700-770-60	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55700-770-01	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55700-770-90	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55700-770-30	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55700-770-60	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55700-770-01	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55700-770-90	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55700-770-30	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55700-770-60	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55700-770-01	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55700-770-90	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	55700-770-01	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	55700-770-60	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	55700-770-90	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	55700-770-30	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	55700-770-01	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	55700-770-60	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	55700-770-90	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	55700-770-30	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	55700-770-01	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	55700-770-60	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	55700-770-90	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	55700-770-30	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	55700-770-01	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	55700-770-60	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	55700-770-90	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	55700-770-30	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A203374-001	CARISOPRODOL	CARISOPRODOL	350MG	TABLET / ORAL	AA		2014-01-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A203374-001	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A203374-001	CARISOPRODOL	350MG	TABLET / ORAL	AA	2014-01-27	`e64feba35796…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A203374-001	AA	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203374-001	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203374-001	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203374-001	AA	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203374-001	AA	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203374-001	AA	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203374-001	AA	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203374-001	AA	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203374-001	AA	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203374-001	AA	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A203374-001	AA	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203374-001	AA	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203374-001	AA	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203374-001	AA	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A203374-001	AA	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203374-001	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A203374-001	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A203374-001	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A203374-001	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A203374-001	AA	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A203374-001	AA	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A203374-001	AA	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A203374-001	AA	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A203374-001	AA	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A203374-001	AA	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A203374-001	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A203374-001	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A203374-001	AA	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A203374-001	AA	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A203374-001	AA	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A203374-001	AA	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A203374-001	AA	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A203374-001	AA	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A203374-001	AA	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A203374-001	AA	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A203374-001	AA	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A203374-001	AA	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A203374-001	AA	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A203374-001	AA	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A203374-001	AA	1	`e64feba35796…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
55700-770-01	2025-01-10	These highlights do not include all the information needed to use CARISOPRODOL tablets, USP safely and effectively. See full prescribing information for CARISOPRODOL tablets, USP. Carisoprodol tablets, USP for Oral use CIV Initial U.S. Approval: 1959
55700-770-30	2025-01-10	These highlights do not include all the information needed to use CARISOPRODOL tablets, USP safely and effectively. See full prescribing information for CARISOPRODOL tablets, USP. Carisoprodol tablets, USP for Oral use CIV Initial U.S. Approval: 1959
55700-770-60	2025-01-10	These highlights do not include all the information needed to use CARISOPRODOL tablets, USP safely and effectively. See full prescribing information for CARISOPRODOL tablets, USP. Carisoprodol tablets, USP for Oral use CIV Initial U.S. Approval: 1959
55700-770-90	2025-01-10	These highlights do not include all the information needed to use CARISOPRODOL tablets, USP safely and effectively. See full prescribing information for CARISOPRODOL tablets, USP. Carisoprodol tablets, USP for Oral use CIV Initial U.S. Approval: 1959
55700-770-01	2023-01-30	These highlights do not include all the information needed to use CARISOPRODOL tablets, USP safely and effectively. See full prescribing information for CARISOPRODOL tablets, USP. Carisoprodol tablets, USP for Oral use CIV Initial U.S. Approval: 1959
55700-770-30	2023-01-30	These highlights do not include all the information needed to use CARISOPRODOL tablets, USP safely and effectively. See full prescribing information for CARISOPRODOL tablets, USP. Carisoprodol tablets, USP for Oral use CIV Initial U.S. Approval: 1959
55700-770-60	2023-01-30	These highlights do not include all the information needed to use CARISOPRODOL tablets, USP safely and effectively. See full prescribing information for CARISOPRODOL tablets, USP. Carisoprodol tablets, USP for Oral use CIV Initial U.S. Approval: 1959
55700-770-90	2023-01-30	These highlights do not include all the information needed to use CARISOPRODOL tablets, USP safely and effectively. See full prescribing information for CARISOPRODOL tablets, USP. Carisoprodol tablets, USP for Oral use CIV Initial U.S. Approval: 1959

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
55700-770-01	EA - Each	55700-770	b829bedf-3f99-4470-b2f1-ffef11f7513b	1	2019-08-06
55700-770-30	EA - Each	55700-770	a308b107-f09a-497b-a5b9-2b5621c5e596	1	2019-08-06
55700-770-60	EA - Each	55700-770	efe225df-0f6d-484d-836a-724db3e6924e	1	2019-08-06
55700-770-90	EA - Each	55700-770	bb368db8-fe6b-419a-bf5d-7e0c8d4df704	1	2019-08-06

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 15 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CARISOPRODOL	CARISOPRODOL	Northwind Health Company, LLC	26e466be-8066-e562-e063-6394a90a9f81	2026-06-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374
CARISOPRODOL	CARISOPRODOL	St. Mary's Medical Park Pharmacy	94f74800-1f0d-7814-e053-2a95a90a4f63	2026-06-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374
CARISOPRODOL	CARISOPRODOL	Bryant Ranch Prepack	269644bf-d32c-48a3-b3eb-1221150ebd22	2026-06-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374
CARISOPRODOL	CARISOPRODOL	Bryant Ranch Prepack	59f6f0e3-fdbd-4788-9944-37edde4b9a3c	2026-05-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374
CARISOPRODOL	CARISOPRODOL	Bryant Ranch Prepack	a3f1343f-1337-4b99-b1ae-4189324ec2e9	2026-05-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374
CARISOPRODOL	CARISOPRODOL	Bryant Ranch Prepack	93f909ea-2d2e-4a10-be50-7f33f3e904d4	2026-05-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374
CARISOPRODOL	CARISOPRODOL	ScieGen Pharmaceuticals, Inc.	069ea892-21a6-4703-8dd3-bf19c4406479	2026-02-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374
Carisoprodol	CARISOPRODOL	Direct_Rx	8e9bb49a-8cc3-4390-e053-2a95a90a4e0e	2026-01-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374
Carisoprodol	CARISOPRODOL	Advanced Rx Pharmacy of Tennessee, LLC	f835e66e-f3f3-c3cf-e053-6294a90addf2	2024-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374
CARISOPRODOL	CARISOPRODOL	Bryant Ranch Prepack	fdd6318f-399f-499c-acdc-5318aa080f36	2024-08-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374
CARISOPRODOL	CARISOPRODOL	NuCare Pharmaceuticals,Inc.	93cbe188-5443-b392-e053-2995a90a9ac7	2024-06-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374
CARISOPRODOL	CARISOPRODOL	Asclemed USA, Inc.	4221d7d1-d7d6-46c4-be41-8c8e99129324	2023-11-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374
CARISOPRODOL	CARISOPRODOL	Proficient Rx LP	2178e805-8189-459f-a447-21bf1547744a	2022-05-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374
CARISOPRODOL	CARISOPRODOL	Proficient Rx LP	efd7a0b4-5ec5-4929-a4cb-7d207171eed6	2019-10-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374
CARISOPRODOL	CARISOPRODOL	Vensun Pharmaceuticals, Inc.	7c6015ad-2158-400d-8c22-585ab277ea49	2018-11-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203374 application number: ANDA203374

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
21925K482H	CARISOPRODOL	78-44-4	CARISOPRODOL

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
55700-770-01	55700077001	120 TABLET in 1 BOTTLE (55700-770-01)	120 tablet	2019-06-28	0000-00-00	No	No	Current
55700-770-30	55700077030	30 TABLET in 1 BOTTLE (55700-770-30)	30 tablet	2019-06-28	0000-00-00	No	No	Current
55700-770-60	55700077060	60 TABLET in 1 BOTTLE (55700-770-60)	60 tablet	2019-06-28	0000-00-00	No	No	Current
55700-770-90	55700077090	90 TABLET in 1 BOTTLE (55700-770-90)	90 tablet	2019-06-28	0000-00-00	No	No	Current